Peptide record

TPDB05246

Chrysophsin-1 Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity standard
25 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB05246
Chrysophsin-1
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia ACP740 _ACP240 AntiCP 2.0 CancerPPD 2.0 SATPdb dbACP iACP-DRLF pep-lab Antifungipept CAFPdb APD_complete APD_hemolytic HemoPI Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 25-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
FFGWLIKGAIHAGKAIHGLIHRRRH
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C136H211N45O26
NDCEQMPSTYV
GHI
2892.46
12.71
9
0
12
+5
1.10
-0.000
105.60
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
5500
1.90
0
Residue Composition
number
3
A
3
R
0
N
0
D
0
C
0
E
0
Q
4
G
4
H
4
I
2
L
2
K
0
M
2
F
0
P
0
S
0
T
1
W
0
Y
0
V
Amino Acid Distribution
A: 3 R: 3 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 4 H: 4 I: 4 L: 2 K: 2 M: 0 F: 2 P: 0 S: 0 T: 0 W: 1 Y: 0 V: 0
Chemical Descriptors
25 reviewed residue count
C136H211N45O26 sequence-only estimate (linear, free termini)
2892.46 sequence-only estimate (linear, free termini)
12.71 sequence-only estimate (linear, free termini)
+5 sequence-only estimate (linear, free termini)
1.10 sequence-only estimate (linear, free termini)
-0.000 sequence-only estimate (linear, free termini)
Free Activity
L Activity
Not Available Activity
Free Activity
Antibacterial Activity
Red sea bream,Chrysophrys majororPagrus major Activity
Evidence Records 29 records
Evidence 1 Activity

Activity

MIC
Antibacterial
2.5 µM

Target

S. iniae F-8502

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against Gram+ L. garvieae YT-3 (ATCC 49156) (MIC 10 uM), S. iniae F-8502 (MIC 2.5 uM), Gram- V. anguillarum ATCC 19264 (MIC 2.5 uM), Vibriopenaeicida KHA (MIC 10 uM), V. harve
Evidence 2 Activity

Activity

MIC
Antibacterial
2.5 µM

Target

V. anguillarum ATCC 19264

Source & Reference

dbAMP DRAMP

Other

inst Gram+ L. garvieae YT-3 (ATCC 49156) (MIC 10 uM), S. iniae F-8502 (MIC 2.5 uM), Gram- V. anguillarum ATCC 19264 (MIC 2.5 uM), Vibriopenaeicida KHA (MIC 10 uM), V. harveyi HUFP911 1 (ATCC 14126) (MIC 2.5 uM), V. vul
Evidence 3 Activity

Activity

MIC
Antibacterial
10 µM

Target

A. salmonicida NCMB 1102

Source & Reference

dbAMP DRAMP

Other

MIC 2.5 uM), V. vulnificus ET-7617(ATCC 33148) (MIC 5 uM), A-hydrophila ET-4 (MIC>40 uM), A. salmonicida NCMB 1102 (MIC 10 uM), P. putida ATCC 12633 (MIC 40 uM), and E-tarda ET-82016 (MIC>40 uM). Bactericidal activit
Evidence 4 Activity

Activity

MIC
Antibacterial
40 µM

Target

P. putida ATCC 12633

Source & Reference

dbAMP DRAMP

Other

C 33148) (MIC 5 uM), A-hydrophila ET-4 (MIC>40 uM), A. salmonicida NCMB 1102 (MIC 10 uM), P. putida ATCC 12633 (MIC 40 uM), and E-tarda ET-82016 (MIC>40 uM). Bactericidal activity (MLC): B. subtilis ATCC 6633 (ML
Evidence 5 Activity

Activity

Not Available
Anticancer

Target

Breast Cancer
Not Available
Not Available

Assay & Model

Not Available
Not Available

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2003

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 6 Activity

Activity

MIC
Antifungal
2.5 µM

Target

S. iniae F-8502

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against Gram+ L. garvieae YT-3 (ATCC 49156) (MIC 10 uM), S. iniae F-8502 (MIC 2.5 uM), Gram- V. anguillarum ATCC 19264 (MIC 2.5 uM), Vibriopenaeicida KHA (MIC 10 uM), V. harve
Evidence 7 Activity

Activity

MIC
Antifungal
2.5 µM

Target

V. anguillarum ATCC 19264

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

inst Gram+ L. garvieae YT-3 (ATCC 49156) (MIC 10 uM), S. iniae F-8502 (MIC 2.5 uM), Gram- V. anguillarum ATCC 19264 (MIC 2.5 uM), Vibriopenaeicida KHA (MIC 10 uM), V. harveyi HUFP911 1 (ATCC 14126) (MIC 2.5 uM), V. vul
Evidence 8 Activity

Activity

MIC
Antifungal
10 µM

Target

A. salmonicida NCMB 1102

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

MIC 2.5 uM), V. vulnificus ET-7617(ATCC 33148) (MIC 5 uM), A-hydrophila ET-4 (MIC>40 uM), A. salmonicida NCMB 1102 (MIC 10 uM), P. putida ATCC 12633 (MIC 40 uM), and E-tarda ET-82016 (MIC>40 uM). Bactericidal activit
Evidence 9 Activity

Activity

MIC
Antifungal
40 µM

Target

P. putida ATCC 12633

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

C 33148) (MIC 5 uM), A-hydrophila ET-4 (MIC>40 uM), A. salmonicida NCMB 1102 (MIC 10 uM), P. putida ATCC 12633 (MIC 40 uM), and E-tarda ET-82016 (MIC>40 uM). Bactericidal activity (MLC): B. subtilis ATCC 6633 (ML
Evidence 10 Activity

Activity

MIC
Antiparasitic
2.5 µM

Target

S. iniae F-8502

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against Gram+ L. garvieae YT-3 (ATCC 49156) (MIC 10 uM), S. iniae F-8502 (MIC 2.5 uM), Gram- V. anguillarum ATCC 19264 (MIC 2.5 uM), Vibriopenaeicida KHA (MIC 10 uM), V. harve
Evidence 11 Activity

Activity

MIC
Antiparasitic
2.5 µM

Target

V. anguillarum ATCC 19264

Source & Reference

DRAMP

Other

inst Gram+ L. garvieae YT-3 (ATCC 49156) (MIC 10 uM), S. iniae F-8502 (MIC 2.5 uM), Gram- V. anguillarum ATCC 19264 (MIC 2.5 uM), Vibriopenaeicida KHA (MIC 10 uM), V. harveyi HUFP911 1 (ATCC 14126) (MIC 2.5 uM), V. vul
Evidence 12 Activity

Activity

MIC
Antiparasitic
10 µM

Target

A. salmonicida NCMB 1102

Source & Reference

DRAMP

Other

MIC 2.5 uM), V. vulnificus ET-7617(ATCC 33148) (MIC 5 uM), A-hydrophila ET-4 (MIC>40 uM), A. salmonicida NCMB 1102 (MIC 10 uM), P. putida ATCC 12633 (MIC 40 uM), and E-tarda ET-82016 (MIC>40 uM). Bactericidal activit
Evidence 13 Activity

Activity

MIC
Antiparasitic
40 µM

Target

P. putida ATCC 12633

Source & Reference

DRAMP

Other

C 33148) (MIC 5 uM), A-hydrophila ET-4 (MIC>40 uM), A. salmonicida NCMB 1102 (MIC 10 uM), P. putida ATCC 12633 (MIC 40 uM), and E-tarda ET-82016 (MIC>40 uM). Bactericidal activity (MLC): B. subtilis ATCC 6633 (ML
Evidence 14 Activity

Activity

MIC
Antiviral
2.5 µM

Target

S. iniae F-8502

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
Active against Gram+ L. garvieae YT-3 (ATCC 49156) (MIC 10 uM), S. iniae F-8502 (MIC 2.5 uM), Gram- V. anguillarum ATCC 19264 (MIC 2.5 uM), Vibriopenaeicida KHA (MIC 10 uM), V. harve
Evidence 15 Activity

Activity

MIC
Antiviral
2.5 µM

Target

V. anguillarum ATCC 19264

Source & Reference

DRAMP

Other

inst Gram+ L. garvieae YT-3 (ATCC 49156) (MIC 10 uM), S. iniae F-8502 (MIC 2.5 uM), Gram- V. anguillarum ATCC 19264 (MIC 2.5 uM), Vibriopenaeicida KHA (MIC 10 uM), V. harveyi HUFP911 1 (ATCC 14126) (MIC 2.5 uM), V. vul
Evidence 16 Activity

Activity

MIC
Antiviral
10 µM

Target

A. salmonicida NCMB 1102

Source & Reference

DRAMP

Other

MIC 2.5 uM), V. vulnificus ET-7617(ATCC 33148) (MIC 5 uM), A-hydrophila ET-4 (MIC>40 uM), A. salmonicida NCMB 1102 (MIC 10 uM), P. putida ATCC 12633 (MIC 40 uM), and E-tarda ET-82016 (MIC>40 uM). Bactericidal activit
Evidence 17 Activity

Activity

MIC
Antiviral
40 µM

Target

P. putida ATCC 12633

Source & Reference

DRAMP

Other

C 33148) (MIC 5 uM), A-hydrophila ET-4 (MIC>40 uM), A. salmonicida NCMB 1102 (MIC 10 uM), P. putida ATCC 12633 (MIC 40 uM), and E-tarda ET-82016 (MIC>40 uM). Bactericidal activity (MLC): B. subtilis ATCC 6633 (ML
Evidence 18 Activity

Activity

% Hemolysis
Hemolysis
10 80 %
[Ref.12581207]10% hemolytic activity at 0.25 µM, 80% hemolytic activity at 1 µM against human erythrocytes

Target

human erythrocytes

Source & Reference

Hemolytik APD_complete APD_hemolytic PD_Hemolysis
DRAMP4
Eur J Biochem. 2003 Feb 270(4):675-686.

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation. Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 19 Activity

Activity

50% Hemolysis
Toxicity
1 µM
Hemolytic Cytotoxic
50% Hemolysis | 1 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Purification and characterization of three isoforms of chrysophsin, a novel antimicrobial peptide in the gills of the red sea bream, Chrysophrys major. | Eur J Biochem | 2003
Evidence 20 Activity

Activity

100% Hemolysis
Toxicity
10 µM
Hemolytic Cytotoxic
100% Hemolysis | 10 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Purification and characterization of three isoforms of chrysophsin, a novel antimicrobial peptide in the gills of the red sea bream, Chrysophrys major. | Eur J Biochem | 2003
Evidence 21 Activity

Activity

EC50
Toxicity
4.6 µM
Cytotoxic
EC50 | 4.6 | µM | target cell: Human fibroblasts MRC-5

Target

Human fibroblasts MRC-5

Source & Reference

NA
DBAASP
Membrane interaction of chrysophsin-1, a histidine-rich antimicrobial peptide from red sea bream. | Biochemistry | 2007
Evidence 22 Activity

Activity

EC50
Toxicity
8.5 µM
Cytotoxic
EC50 | 8.5 | µM | target cell: Human fibroblasts MRC-5

Target

Human fibroblasts MRC-5

Source & Reference

NA
DBAASP
Membrane interaction of chrysophsin-1, a histidine-rich antimicrobial peptide from red sea bream. | Biochemistry | 2007
Evidence 23 Activity

Activity

EC50
Toxicity
4.8 µM
Cytotoxic
EC50 | 4.8 | µM | target cell: Human fibroblasts MRC-5 SV2

Target

Human fibroblasts MRC-5 SV2

Source & Reference

NA
DBAASP
Membrane interaction of chrysophsin-1, a histidine-rich antimicrobial peptide from red sea bream. | Biochemistry | 2007
Evidence 24 Activity

Activity

EC50
Toxicity
9.6 µM
Cytotoxic
EC50 | 9.6 | µM | target cell: Human fibroblasts MRC-5 SV2

Target

Human fibroblasts MRC-5 SV2

Source & Reference

NA
DBAASP
Membrane interaction of chrysophsin-1, a histidine-rich antimicrobial peptide from red sea bream. | Biochemistry | 2007
Evidence 25 Activity

Activity

80% Hemolysis
Toxicity
5 µM
Hemolytic Cytotoxic
80% Hemolysis | 5 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Identification of GXXXXG motif in Chrysophsin-1 and its implication in the design of analogs with cell-selective antimicrobial and anti-endotoxin activities. | Sci Rep | 2017
Evidence 26 Activity

Activity

95% Hemolysis
Toxicity
10 µM
Hemolytic Cytotoxic
95% Hemolysis | 10 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Identification of GXXXXG motif in Chrysophsin-1 and its implication in the design of analogs with cell-selective antimicrobial and anti-endotoxin activities. | Sci Rep | 2017
Evidence 27 Activity

Activity

100% Hemolysis
Toxicity
20 µM
Hemolytic Cytotoxic
100% Hemolysis | 20 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Identification of GXXXXG motif in Chrysophsin-1 and its implication in the design of analogs with cell-selective antimicrobial and anti-endotoxin activities. | Sci Rep | 2017
Evidence 28 Activity

Activity

Toxicity
Hemolytic
Hemolytic_activity: [Ref.12581207]10% hemolytic activity at 0.25 µM, 80% hemolytic activity at 1 µM against human erythrocytes

Target

erythrocytes

Source & Reference

NA
DRAMP
Eur J Biochem. 2003 Feb 270(4):675-686.
Evidence 29 Hemolysis

Activity

10 80 %
% Hemolysis
[Ref.12581207]10% hemolytic activity at 0.25 µM, 80% hemolytic activity at 1 µM against human erythrocytes
Hemolysis

Target

human erythrocytes

Source & Reference

APD_complete APD_hemolytic HemoPI PD_Hemolysis
Eur J Biochem. 2003 Feb 270(4):675-686.
DRAMP4
APD_complete APD_hemolytic PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation.